Indian New Treatment for Asthma and COPD Drug Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Asia
  • Country: India
  • Report ID : 4942

  • Format: PPT, PDF

Indian New Treatment for Asthma and COPD Drug Market: Segmented by Treatment Analysis (Long Term Control Medication, Quick-Relief Medication), by Route of Administration (Oral, Injectable, Inhalation), by Distribution Channel (Hospital, Retail & Online Pharmacies) – Growth, Trends, and Forecast (2019 – 2028)

SKU: 4942 Categories: ,

Report Overview
Indian New Treatment for Asthma & COPD Drugs market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast periodIn India, the Asthma is one of most common chronic disease. In India about 6% of children and 2% of adults have asthma. Nearly 7 million of sufferers are men and just over six million women, while the worst-affected age group is the 15-35-year-olds. The prevalence of occurrence of Asthma in India amongst the Indian children has increased exponentially due to growing air pollution and poor quality of air. It is estimated that in every 1.5-2 crore asthma patients, at least one in every 10 asthma patient globally lives in India. India contributes very significantly to mortality from COPD 102.3/100,000 and 6,740,000 DALYs out of world total of 27,756,000 DALYs; thus significantly affecting health related Quality of Life in the country. About XX% of people in India have COPD who were smokers or former smokers. There are 30 million COPD patients in India. India contributes a significant and growing percentage of COPD mortality which is estimated to be amongst the highest in the world i.e. more than 64.7 estimated age standardized death rate per 100,000 amongst both sexes. This would translate to about 556,000 in case of India (>20%) out of a world total of 2,748,000 annually. COPD is the second most common cause of NCD-related deaths in India, with the age-specific prevalence of COPD increasing rapidly after the age of 30 years. The risk factors for the development of Asthma are a complex interplay of genetic susceptibility and exposure to environmental particulate allergens and substances like indoor and outdoor allergens, tobacco smoke, chemical irritants in the workplace and air pollution.

Market Drivers

The increasing prevalence of asthma, increase in world ageing population, technological advancement in the treatment of asthma, increase in pipeline products growth in initiatives implemented by the government and non-government associations for rise in health awareness are the major factors that drive the growth of the Asthma. The other drivers can be considered as the increasing need for better clinical and therapeutics for asthma in the light of the covid-19 pandemic. An increasing number of product launches are expected to drive the growth of the asthma and COPD drugs market. An increase in the awareness programmes and initiatives to support the major pharmaceutical players to implement advanced R&D and drug development will boost this market in India.

1. Indian New Treatment for Asthma & COPD Drug Market Overview………
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. Increasing Prevalence of Infectious Disease
B. High Exposure to Airborne Allergens
C. Increasing Number of Product Launches and Government Awareness Programs
3. Major Drug Class of Asthma………………………..…………………………………
A. Bronchodilators
B. Anti-inflammatory agents
C. Antileukotriene
4. Indian New Treatment for Asthma & COPD Drug Market Segmentation
A. By Treatment analysis
I. Long term control medication
II. Quick-relief medication
III. Macrolides
IV. Phenicols
B. By Distribution channels
I. Hospitals
II. Retail
III. Online
C. By Route of administration
I. Oral
II. Injectable
III. Inhalation
5. New Treatment for Asthma & COPD Major Products Market Share…
A. Key Findings
B. Market Analysis, Insights, and Forecast
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Lupin Company overview, Product & Services, Strategies & Financials
C. Sanofi Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of New Treatment for Asthma & COPD drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment analysis:

Based on the treatment analysis, the market is segmented into long term control medication and quick relief medication. Since asthma is a chronic disease so the long-term segment usually dominates the market, but the other segment provides quick relief by the relaxation of airway muscles.

By Route of administration:

Based on the route of administration, the market is segmented into injectable, oral, and inhalation. The inhalation segment is anticipated to dominate the market because a significant number of products for the treatment of asthma are administered in this form. The injectable segment is estimated to experience growth in the forecasted period while the oral segment is anticipated to experience limited growth in the forecasted period.

By distribution channels:

Based on the distribution channels, the market is segmented into hospital, retail and online pharmacies. The key reason for the dominance of hospitals can be attributed to the fact that prescription of asthma can only be done in a hospital setting. Online pharmacies are anticipated to grow at a high CAGR because of the ease and convenience given to patients in terms of acquiring critical asthma medications.


Major Players.

As the growing drug-treated population and a rising number of higher-income, brand-conscious asthma patients demanding more efficacious agents in India. The major market players include GlaxoSmithKline PLC., Novartis International AG., Sanofi, AstraZeneca, Lupin, Aerocrine (Circassia). AstraZeneca Pharma has received the permission paves way for the launch of Benralizumab (Fasenra) in India. Cipla, has received the final approval for its asthma medication albuterol (an inhaler) from the US Food and Drug Administration. Albuterol is first generic metered dose inhaler of Proventil ever approved by USFDA and Cipla’s first device-based inhalation product in the market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements